Head-to-head
MEDVi vs Fridays
Compared on both medications across the eight dimensions this database records. They differ on 2 of those eight. Fridays is cheaper on all-in tirzepatide at 10 mg/week, though on a flat-versus-tiered matchup the cheaper program can change further up the dose ladder.
The short answer
MEDVi is $399 a month all-in for tirzepatide; Fridays is $359. Over twelve months that is $4,788 against $4,308. Value Scores are 57.4 and 60.7 out of 100.
Tirzepatide
Plan pages: MEDVi plans · Fridays plans
At 10 mg/week, MEDVi is $399 a month all-in and Fridays is $359 — $40 apart, or $480 across a year. Over twelve months the totals are $4,788 (billed monthly) and $4,308 (billed monthly).
MEDVi charges a flat $399 per month for tirzepatide at every dose from 2.5 to 15 mg per week, so titrating upward does not change what you pay.
Fridays charges a flat $359 per month for tirzepatide at every dose from 2.5 to 15 mg per week, so titrating upward does not change what you pay.
| Dose | MEDVi | Rank | Fridays | Rank | Cheaper |
|---|---|---|---|---|---|
| 2.5 mg | $399 | 27/31 | $359 | 26/31 | Fridays by $40 |
| 5 mg | $399 | 15/17 | $359 | 13/17 | Fridays by $40 |
| 7.5 mg | $399 | 14/17 | $359 | 13/17 | Fridays by $40 |
| 10 mg | $399 | 21/27 | $359 | 19/27 | Fridays by $40 |
| 12.5 mg | $399 | 14/17 | $359 | 13/17 | Fridays by $40 |
| 15 mg | $399 | 14/17 | $359 | 13/17 | Fridays by $40 |
Fridays is cheaper at every dose where both publish a price, so the lead does not change as you titrate.
Across the 27 programs this database can rank on tirzepatide, MEDVi sits 21 of 27 on all-in monthly cost and Fridays sits 18. There are 2 other programs priced between them. The field median is $339 and the floor is $169, so both sit above the median. MEDVi is $230 above the cheapest tirzepatide program on record. Fridays is $190 above the cheapest tirzepatide program on record.
LillyDirect (Zepbound), the lowest FDA-approved tirzepatide channel here, is $449 a month — MEDVi undercuts it by $50, Fridays by $90. Compounded products are not FDA approved; insurance can reverse that comparison.
| Plan term | MEDVi | Fridays | Cheaper |
|---|---|---|---|
| Month to month | $399 | $359 | Fridays by $40 |
| Settled dose | MEDVi | Fridays | Difference |
|---|---|---|---|
| 2.5 mg | $4,788 | $4,308 | $480 apart |
| 5 mg | $4,788 | $4,308 | $480 apart |
| 7.5 mg | $4,788 | $4,308 | $480 apart |
| 10 mg | $4,788 | $4,308 | $480 apart |
| 12.5 mg | $4,788 | $4,308 | $480 apart |
| 15 mg | $4,788 | $4,308 | $480 apart |
MEDVi publishes no rate for 3-month term, 6-month term, 12-month term; Fridays publishes none for 3-month term, 6-month term, 12-month term. An unpublished term is not necessarily unavailable — it is unpriced in public, which you can only resolve by asking.
A titration year is not twelve months at the maintenance price. Stepping up roughly four weeks per dose before settling at 10 mg/week, the first twelve months work out to $4,788 on MEDVi and $4,308 on Fridays. Both programs charge one flat rate, so the ramp costs the same as any other stretch of the year.
Value Scores are 57.4 for MEDVi and 60.7 for Fridays, against a tirzepatide category floor of $169. Fridays leads by 3.3 points, driven mostly by price.
| Program | Price /70 | Evidence /15 | Dose /10 | Membership /5 | Total /100 |
|---|---|---|---|---|---|
| MEDVi | 29.6 | 12.8 | 10 | 5 | 57.4 |
| Fridays | 33.0 | 12.8 | 10 | 5 | 60.7 |
Semaglutide
Plan pages: MEDVi plans · Fridays plans
At 2.4 mg/week, MEDVi is $299 a month all-in and Fridays is $175 — $124 apart, or $1,488 across a year. Over twelve months the totals are $3,588 (billed monthly) and $2,100 (billed monthly).
MEDVi charges a flat $299 per month for semaglutide at every dose from 0.25 to 2.4 mg per week, so titrating upward does not change what you pay.
Fridays charges a flat $175 per month for semaglutide at every dose from 0.25 to 2.4 mg per week, so titrating upward does not change what you pay.
Fridays is cheaper at every dose where both publish a price, so the lead does not change as you titrate.
Value Scores are 58.0 for MEDVi and 79.3 for Fridays, against a semaglutide category floor of $129. Fridays leads by 21.3 points, driven mostly by price.
Where the two programs differ
All-in monthly
Fridays is cheaper month to month — $359 against $399, a gap of $40 every month, or $480 across a year if both rates hold.
Twelve-month cost
Over twelve months the totals are $4,788 for MEDVi and $4,308 for Fridays. Fridays is lower by $480 — a figure worth checking against the cancellation terms below, because a prepaid year is only cheaper if you stay on it.
Cancellation terms
Both state the same cancellation terms: Cancel before renewal.
Commitment
Commitment terms read the same on both: Month-to-month.
Dose policy
Both hold one price across the whole dose ladder, so neither punishes titration and the monthly figures above are what you actually pay at 15 mg as well as at 2.5 mg.
Evidence status
Both figures carry the same evidence status, provider-stated: taken from the provider's own published pages; checkout capture pending. Neither is stronger than the other on provenance.
Membership fee
Neither charges a separate membership fee.
Shipping
Shipping is handled the same way by both — included in the quoted price.
What each record says
MEDVi Official site
MEDVi advertises a $179 semaglutide start that tiers to $299 at maintenance; tirzepatide is $399 flat.
It does not publicly name its compounding pharmacy; the record shows Partner pharmacies, so who actually makes the medication cannot be independently verified; commitment terms are Month-to-month; cancellation is Cancel before renewal; availability is stated as Most US states.
Evidence: provider-stated — taken from the provider's own published pages; checkout capture pending, captured . Source — medvi.com pricing capture 2026-08-05
Watch: Start-vs-maintenance spread on semaglutide; compare on maintenance.
Fridays Official site
Fridays runs flat no-membership pricing: $175/month semaglutide, $359/month tirzepatide.
It does not publicly name its compounding pharmacy; the record shows Partner pharmacies, so who actually makes the medication cannot be independently verified; commitment terms are Month-to-month; cancellation is Cancel before renewal; availability is stated as Most US states.
Evidence: provider-stated — taken from the provider's own published pages; checkout capture pending, captured . Source — joinfridays.com pricing capture 2026-08-05
Watch: Provider-stated; checkout capture pending.
What neither record tells you
MEDVi does not publish
- no published twelve-month tirzepatide rate
- no published twelve-month semaglutide rate
- no named compounding pharmacy
- no state-by-state availability list — it says Most US states
Fridays does not publish
- no published twelve-month tirzepatide rate
- no published twelve-month semaglutide rate
- no named compounding pharmacy
- no state-by-state availability list — it says Most US states
Ask MEDVi and Fridays for each of those in writing before enrolling. A gap is not evidence of a problem; it does mean nothing can be checked against it.
What would change this answer
Neither program publishes a promotional rate with an end date, a prepaid term, or a price we have flagged for re-verification, so the comparison above is as stable as this dataset gets.
Which one suits which reader
On the lowest standing monthly rate for tirzepatide, Fridays Official site wins this matchup. On the structural dimensions the two are close enough that the choice comes down to availability in your state and which intake you prefer.
Both figures should be checked at the provider's own checkout before you pay. MEDVi's tirzepatide price is provider-stated as of 2026-08-05; Fridays's is provider-stated as of 2026-08-05.
Questions
Is MEDVi or Fridays cheaper for tirzepatide?
Fridays is cheaper on all-in monthly cost at 10 mg/week: $359 against $399, a difference of $40 a month. All-in means the medication plus every mandatory recurring fee.
What is the twelve-month cost of MEDVi versus Fridays?
MEDVi works out to $4,788 across twelve months and Fridays to $4,308, on the plan terms each publishes.
Does MEDVi or Fridays raise the price as the dose goes up?
MEDVi: no, it charges one flat rate at every dose. Fridays: no, it charges one flat rate at every dose. Where one program is flat and the other is tiered, the cheaper of the two can change as you titrate upward.
How many ways do MEDVi and Fridays differ?
2 of the eight dimensions this site records: all-in monthly, twelve-month cost, dose policy, membership, shipping, commitment, cancellation terms and evidence status.
Which of MEDVi and Fridays names its pharmacy?
Neither. MEDVi records Partner pharmacies and Fridays records Partner pharmacies. Without a named pharmacy, neither program's licensing or inspection history can be checked before you order.
How well evidenced are the MEDVi and Fridays prices?
MEDVi's tirzepatide figure is provider-stated — taken from the provider's own published pages; checkout capture pending — captured 2026-08-05. Fridays's is provider-stated, captured 2026-08-05. Evidence status is worth fifteen points in the Value Score, so it is priced in rather than mentioned as an aside.
Which is cheaper for semaglutide?
Fridays, at $175 a month all-in against $299 at 2.4 mg/week. The two programs do not necessarily lead on both medications.
Official sources: MEDVi official site · Fridays official site. Compounded tirzepatide and semaglutide are not FDA-approved products.